organization · Reporting owner

ACCESS INDUSTRIES MANAGEMENT, LLC

Disclosed activity across 16 companies

Tapewire entity: 46925
SEC CIK: 0001508226

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Chemomab Therapeutics Ltd.ANCN · Entity 7653	Affiliate of 10% Owner	January 01, 2020	January 02, 2020
Climb Bio, Inc.ELYM · Entity 5064	Affiliate of 10% Owner	August 12, 2021	August 16, 2021
DigitalOcean Holdings, Inc.DOCN · Entity 2625	Affiliate of 10% Owner	May 13, 2026	May 16, 2026
Gamida Cell Ltd.GMDA · Entity 94655	10% owner	January 01, 2022	January 13, 2022
Hemab Therapeutics Holdings, Inc.COAG · Entity 4476	10% owner	May 04, 2026	May 14, 2026
LyondellBasell Industries N.V.LYB · Entity 3246	10% owner	March 09, 2026	March 11, 2026
OnKure Therapeutics, Inc.OKUR · Entity 6550	10% owner	March 31, 2026	April 08, 2026
Pandion Therapeutics, Inc.PAND · Entity 11788	10% owner	July 16, 2020	July 16, 2020
Upstream Bio, Inc.UPB · Entity 5743	10% owner	October 15, 2024	October 17, 2024
Verona Pharma plcVRNA · Entity 74409	10% owner	August 15, 2022	August 17, 2022
Warner Music Group Corp.WMG · Entity 2076	10% owner	April 16, 2026	April 20, 2026
Yarrow Bioscience, Inc.VYNE · Entity 6871	10% owner	November 01, 2023	November 13, 2023
Zura Bio LtdZURA · Entity 5413	10% owner	February 26, 2026	March 02, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Chemomab Therapeutics Ltd.

Report date January 01, 2020 · Filed January 02, 2020

Jointly reported with Access Industries Holdings LLC, Clal Biotechnology Industries Ltd., ACCESS INDUSTRIES, LLC, Blavatnik Len

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	Direct	6,521,753	Reported balance Holding disclosure · report date 2020-01-01 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 6,521,753 F1: Consists of 1,304,347 American Depositary Shares ("ADSs"), each of which represents five ordinary shares, no par value ("Ordinary Shares"), of the Issuer, evidenced by American Depositary Receipts. F2: The securities reported are held directly by Access Industries Holdings LLC ("AIH") and may be deemed to be beneficially owned by Access Industries, LLC ("Access LLC"), Access Industries Management, LLC ("Management LLC") and Len Blavatnik, because Access LLC holds a majority of the outstanding voting interests in AIH, Management LLC controls Access LLC and AIH, and Len Blavatnik controls Management LLC and Access LLC. Each of the reporting persons (other than AIH) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, if any, and this Form shall not be construed as an admission that any such reporting person (other than AIH) is the beneficial owner of such securities for any purpose.
Ordinary SharesSEC Table I · non-derivative	Direct	6,911,166	Reported balance Holding disclosure · report date 2020-01-01 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 6,911,166 F3: Consists of 6,585,081 Ordinary Shares and 65,217 ADSs. F4: The securities reported are held directly by Clal Biotechnology Industries Ltd. ("CBI"). AIH, Access LLC, Management LLC and Len Blavatnik may be deemed to beneficially own the securities held directly by CBI because Clal Industries Ltd. ("CI") is the controlling shareholder of CBI, AIH controls CI, Access LLC holds a majority of the outstanding interests in AIH, Management LLC controls Access LLC, and Len Blavatnik controls Management LLC and Access LLC. Each of the reporting persons (other than CBI) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, if any, and this Form shall not be construed as an admission that any such reporting person (other than CBI) is the beneficial owner of such securities for any purpose.
WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.93 · Expires 2023-06-29	Direct	Not disclosed	Reported balance Holding disclosure · report date 2020-01-01 · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · Balance Not disclosed F5: On June 29, 2018, pursuant to a securities purchase agreement, dated March 29, 2018, between the Issuer and certain investors, CBI was issued a warrant to purchase 1,041,185 Ordinary Shares, as partial consideration for repayment of financing that was provided to the Issuer by CBI. Pursuant to the warrant agreement, dated June 20, 2018 (the "Warrant Agreement"), each warrant is exercisable for one Ordinary Share. F6: CBI may elect to exercise the warrant in whole or in part and from time to time at any time until June 29, 2023, in cash or on a net issuance basis, in an amount equal to the aggregate exercise price for the Ordinary Shares being acquired upon exercise. The number of Ordinary Shares purchasable upon exercise of the warrant and the exercise price is subject to adjustments, as set forth in the Warrant Agreement. On February 14, 2019, in connection with the closing of the Issuer's initial public offering of ADSs, as a result of triggering certain price protection rights, the warrant was adjusted to provide for the purchase of an additional 1,355,311 Ordinary Shares from the Issuer. F4: The securities reported are held directly by Clal Biotechnology Industries Ltd. ("CBI"). AIH, Access LLC, Management LLC and Len Blavatnik may be deemed to beneficially own the securities held directly by CBI because Clal Industries Ltd. ("CI") is the controlling shareholder of CBI, AIH controls CI, Access LLC holds a majority of the outstanding interests in AIH, Management LLC controls Access LLC, and Len Blavatnik controls Management LLC and Access LLC. Each of the reporting persons (other than CBI) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, if any, and this Form shall not be construed as an admission that any such reporting person (other than CBI) is the beneficial owner of such securities for any purpose.
Employee stock optionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.47 · Expires 2029-11-13	Direct	Not disclosed	Reported balance Holding disclosure · report date 2020-01-01 · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · Balance Not disclosed F7: One-third of the options vest on November 10, 2020 and one-twelfth at the end of each calendar quarter thereafter, until fully vested. F4: The securities reported are held directly by Clal Biotechnology Industries Ltd. ("CBI"). AIH, Access LLC, Management LLC and Len Blavatnik may be deemed to beneficially own the securities held directly by CBI because Clal Industries Ltd. ("CI") is the controlling shareholder of CBI, AIH controls CI, Access LLC holds a majority of the outstanding interests in AIH, Management LLC controls Access LLC, and Len Blavatnik controls Management LLC and Access LLC. Each of the reporting persons (other than CBI) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, if any, and this Form shall not be construed as an admission that any such reporting person (other than CBI) is the beneficial owner of such securities for any purpose.

Filing footnotes · ownership attribution and instrument terms

F1: Consists of 1,304,347 American Depositary Shares ("ADSs"), each of which represents five ordinary shares, no par value ("Ordinary Shares"), of the Issuer, evidenced by American Depositary Receipts.

F2: The securities reported are held directly by Access Industries Holdings LLC ("AIH") and may be deemed to be beneficially owned by Access Industries, LLC ("Access LLC"), Access Industries Management, LLC ("Management LLC") and Len Blavatnik, because Access LLC holds a majority of the outstanding voting interests in AIH, Management LLC controls Access LLC and AIH, and Len Blavatnik controls Management LLC and Access LLC. Each of the reporting persons (other than AIH) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, if any, and this Form shall not be construed as an admission that any such reporting person (other than AIH) is the beneficial owner of such securities for any purpose.

F3: Consists of 6,585,081 Ordinary Shares and 65,217 ADSs.

F4: The securities reported are held directly by Clal Biotechnology Industries Ltd. ("CBI"). AIH, Access LLC, Management LLC and Len Blavatnik may be deemed to beneficially own the securities held directly by CBI because Clal Industries Ltd. ("CI") is the controlling shareholder of CBI, AIH controls CI, Access LLC holds a majority of the outstanding interests in AIH, Management LLC controls Access LLC, and Len Blavatnik controls Management LLC and Access LLC. Each of the reporting persons (other than CBI) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, if any, and this Form shall not be construed as an admission that any such reporting person (other than CBI) is the beneficial owner of such securities for any purpose.

F5: On June 29, 2018, pursuant to a securities purchase agreement, dated March 29, 2018, between the Issuer and certain investors, CBI was issued a warrant to purchase 1,041,185 Ordinary Shares, as partial consideration for repayment of financing that was provided to the Issuer by CBI. Pursuant to the warrant agreement, dated June 20, 2018 (the "Warrant Agreement"), each warrant is exercisable for one Ordinary Share.

F6: CBI may elect to exercise the warrant in whole or in part and from time to time at any time until June 29, 2023, in cash or on a net issuance basis, in an amount equal to the aggregate exercise price for the Ordinary Shares being acquired upon exercise. The number of Ordinary Shares purchasable upon exercise of the warrant and the exercise price is subject to adjustments, as set forth in the Warrant Agreement. On February 14, 2019, in connection with the closing of the Issuer's initial public offering of ADSs, as a result of triggering certain price protection rights, the warrant was adjusted to provide for the purchase of an additional 1,355,311 Ordinary Shares from the Issuer.

F7: One-third of the options vest on November 10, 2020 and one-twelfth at the end of each calendar quarter thereafter, until fully vested.

Climb Bio, Inc.

Report date August 12, 2021 · Filed August 16, 2021

Jointly reported with AI ETI LLC, Access Industries Holdings LLC, Blavatnik Len

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	5,009,400	Last balance in matching sequence After 2021-08-12 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2021-08-12 · Conversion · Acquired 4,209,400 · Balance 4,209,400 F1: Each share of Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock was automatically converted into one share of common stock upon the completion of Eliem Therapeutics, Inc.'s (the "Issuer") initial public offering and had no expiration date. F2: The securities reported are held directly by AI ETI LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI ETI LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form. Row 2 · 2021-08-12 · Purchase · Acquired 800,000 · Balance 5,009,400 F3: Represents securities purchased in the Issuer's initial public offering. F2: The securities reported are held directly by AI ETI LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI ETI LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.
Series A Redeemable Convertible Preferred StockSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2021-08-12 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2021-08-12 · Conversion · Disposed 3,568,375 · Balance 0 F1: Each share of Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock was automatically converted into one share of common stock upon the completion of Eliem Therapeutics, Inc.'s (the "Issuer") initial public offering and had no expiration date. F2: The securities reported are held directly by AI ETI LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI ETI LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.
Series B Redeemable Convertible Preferred StockSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2021-08-12 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2021-08-12 · Conversion · Disposed 641,025 · Balance 0 F1: Each share of Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock was automatically converted into one share of common stock upon the completion of Eliem Therapeutics, Inc.'s (the "Issuer") initial public offering and had no expiration date. F2: The securities reported are held directly by AI ETI LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI ETI LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock was automatically converted into one share of common stock upon the completion of Eliem Therapeutics, Inc.'s (the "Issuer") initial public offering and had no expiration date.

F2: The securities reported are held directly by AI ETI LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI ETI LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.

F3: Represents securities purchased in the Issuer's initial public offering.

DigitalOcean Holdings, Inc.

Report date May 13, 2026 · Filed May 16, 2026

Jointly reported with Access Industries Holdings LLC, AI Droplet Holdings LLC, AI Droplet Sharing LLC, AI Droplet Subsidiary LLC, Blavatnik Len

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy LLC	18,378,199	Reported balance After 2026-05-13 transaction · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · 2026-05-13 · Sale · Disposed 3,278,988 · Balance 18,378,199 F1: The shares of common stock were sold in an unregistered block sale transaction pursuant to Rule 144 under the Securities Act of 1933, as amended, at a price per share of $150.30. F2: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F3: The securities reported are held directly by AI Droplet Holdings LLC ("Holdings") and may be deemed to be beneficially owned by Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) AIM is the sole manager of Holdings and (ii) Len Blavatnik controls AIM and a majority of the outstanding voting interests in Holdings.
Common StockSEC Table I · non-derivative	IndirectBy LLC	119,587	Reported balance After 2026-05-13 transaction · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · 2026-05-13 · Sale · Disposed 21,012 · Balance 119,587 F1: The shares of common stock were sold in an unregistered block sale transaction pursuant to Rule 144 under the Securities Act of 1933, as amended, at a price per share of $150.30. F2: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F4: The securities reported are held directly by AI Droplet Subsidiary LLC ("Subsidiary") and may be deemed to be beneficially owned by AIM, Holdings and Len Blavatnik because (i) AIM is the sole manager of Subsidiary and Holdings, (ii) Holdings owns all of the equity interests in Subsidiary and (iii) Len Blavatnik controls AIM and a majority of the outstanding voting interests in Holdings.
Common StockSEC Table I · non-derivative	IndirectBy LLC	155,665	Reported balance Holding disclosure · report date 2026-05-13 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 155,665 F2: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F5: The securities reported are held directly by AI Droplet Sharing LLC ("Sharing") and may be deemed to be beneficially owned by AIM, Access Industries Holdings LLC ("AIH") and Len Blavatnik because (i) AIM is the sole manager of Sharing and AIH, (ii) AIH controls all of the outstanding voting interests in Sharing and (iii) Len Blavatnik controls AIM and a majority of the outstanding. voting interests in AIH.

Filing footnotes · ownership attribution and instrument terms

F1: The shares of common stock were sold in an unregistered block sale transaction pursuant to Rule 144 under the Securities Act of 1933, as amended, at a price per share of $150.30.

F2: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities.

F3: The securities reported are held directly by AI Droplet Holdings LLC ("Holdings") and may be deemed to be beneficially owned by Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) AIM is the sole manager of Holdings and (ii) Len Blavatnik controls AIM and a majority of the outstanding voting interests in Holdings.

F4: The securities reported are held directly by AI Droplet Subsidiary LLC ("Subsidiary") and may be deemed to be beneficially owned by AIM, Holdings and Len Blavatnik because (i) AIM is the sole manager of Subsidiary and Holdings, (ii) Holdings owns all of the equity interests in Subsidiary and (iii) Len Blavatnik controls AIM and a majority of the outstanding voting interests in Holdings.

F5: The securities reported are held directly by AI Droplet Sharing LLC ("Sharing") and may be deemed to be beneficially owned by AIM, Access Industries Holdings LLC ("AIH") and Len Blavatnik because (i) AIM is the sole manager of Sharing and AIH, (ii) AIH controls all of the outstanding voting interests in Sharing and (iii) Len Blavatnik controls AIM and a majority of the outstanding. voting interests in AIH.

Gamida Cell Ltd.

Report date January 01, 2022 · Filed January 13, 2022 · Amendment

Jointly reported with Access Industries Holdings LLC, Clal Biotechnology Industries Ltd., Bio Medical Investment (1997) Ltd., ACCESS INDUSTRIES, LLC, Blavatnik Len, AI Gamida Holdings LLC

Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.

This filing explicitly reported no securities owned.

Hemab Therapeutics Holdings, Inc.

Report date May 04, 2026 · Filed May 14, 2026

Jointly reported with AI DEN-MAB LLC, AI Biotechnology LLC, Access Industries Holdings LLC, Blavatnik Len

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	4,876,344	Reported balance Holding disclosure · report date 2026-05-04 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 4,876,344 F1: The securities reported are held directly by AI DEN-MAB LLC ("AI DMAB") and may be deemed to be beneficially owned by AI Biotechnology LLC ("AIB"), Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH and AIB, (iii) AIH owns all of the voting units of AIB, and (iv) AIB owns all of the voting units of AI DMAB. Each of AIH, AIB, AIM and Mr. Blavatnik, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.

Filing footnotes · ownership attribution and instrument terms

F1: The securities reported are held directly by AI DEN-MAB LLC ("AI DMAB") and may be deemed to be beneficially owned by AI Biotechnology LLC ("AIB"), Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH and AIB, (iii) AIH owns all of the voting units of AIB, and (iv) AIB owns all of the voting units of AI DMAB. Each of AIH, AIB, AIM and Mr. Blavatnik, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.

LyondellBasell Industries N.V.

Report date March 09, 2026 · Filed March 11, 2026

Jointly reported with AI INVESTMENTS HOLDINGS LLC, Access Industries Holdings LLC, ACCESS INDUSTRIES, LLC, Blavatnik Len

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary sharesSEC Table I · non-derivative	IndirectBy LLC	1,000,000	Reported balance After 2026-03-09 transaction · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · 2026-03-09 · Gift · Disposed 464,610 · Balance 1,000,000 F1: These shares were donated by Access Industries Core Holdings LLC (formerly AIPH Holdings LLC) ("AICH") for no consideration as a charitable contribution. F2: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F3: The securities reported are held directly by AICH and may be deemed to be indirectly beneficially owned by Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because Access Industries Holdings LLC controls a majority of the outstanding voting interests in AICH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC and AICH and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC.
Ordinary sharesSEC Table I · non-derivative	IndirectBy LLC	5,574,787	Reported balance After 2026-03-09 transaction · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · 2026-03-09 · Sale · Disposed 80,679 · Balance 5,574,787 F4: The price reported in Column 4 is a weighted average sales price of the ordinary shares. The ordinary shares were sold in multiple transactions ranging from $66.72 to $67.7193 inclusive. The reporting persons undertake to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F7: Because of their relationships with the other reporting persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC) ("AICH"). Each of the reporting persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of AI Altep Investments LLC and AICH. F8: The securities reported are held directly by AICH and may be deemed to be indirectly beneficially owned by Access Industries Management, LLC, Access Industries Holdings LLC and Len Blavatnik because Mr. Blavatnik controls Access Industries Management, LLC, Access Industries Holdings LLC owns a majority of the outstanding voting interests in RSB 2 Limited which is the sole member of AICH, and Access Industries Management, LLC controls AICH and Access Industries Holdings LLC.
Ordinary sharesSEC Table I · non-derivative	IndirectBy LLC	5,385,510	Reported balance After 2026-03-09 transaction · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · 2026-03-09 · Sale · Disposed 189,277 · Balance 5,385,510 F5: The price reported in Column 4 is a weighted average sales price of the ordinary shares. The ordinary shares were sold in multiple transactions ranging from $67.72 to $68.715 inclusive. The reporting persons undertake to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F7: Because of their relationships with the other reporting persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC) ("AICH"). Each of the reporting persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of AI Altep Investments LLC and AICH. F8: The securities reported are held directly by AICH and may be deemed to be indirectly beneficially owned by Access Industries Management, LLC, Access Industries Holdings LLC and Len Blavatnik because Mr. Blavatnik controls Access Industries Management, LLC, Access Industries Holdings LLC owns a majority of the outstanding voting interests in RSB 2 Limited which is the sole member of AICH, and Access Industries Management, LLC controls AICH and Access Industries Holdings LLC.
Ordinary sharesSEC Table I · non-derivative	IndirectBy LLC	5,270,918	Reported balance After 2026-03-09 transaction · row 6 Holding and transaction disclosures are not merged. 1 source row Row 6 · 2026-03-09 · Sale · Disposed 114,592 · Balance 5,270,918 F6: The price reported in Column 4 is a weighted average sales price of the ordinary shares. The ordinary shares were sold in multiple transactions ranging from $68.72 to $69.19 inclusive. The reporting persons undertake to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F7: Because of their relationships with the other reporting persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC) ("AICH"). Each of the reporting persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of AI Altep Investments LLC and AICH. F8: The securities reported are held directly by AICH and may be deemed to be indirectly beneficially owned by Access Industries Management, LLC, Access Industries Holdings LLC and Len Blavatnik because Mr. Blavatnik controls Access Industries Management, LLC, Access Industries Holdings LLC owns a majority of the outstanding voting interests in RSB 2 Limited which is the sole member of AICH, and Access Industries Management, LLC controls AICH and Access Industries Holdings LLC.
Ordinary sharesSEC Table I · non-derivative	IndirectBy LLC	41,195,179	Reported balance Holding disclosure · report date 2026-03-09 · row 8 Holding and transaction disclosures are not merged. 1 source row Row 8 · Balance 41,195,179 F2: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F10: The securities reported are held directly by LYB Holdco LLC (formerly AI International Chemicals LLC) ("LYB Holdco") and may be deemed to be indirectly beneficially owned by AIIH, Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because AIIH holds a majority of the outstanding voting interests in LYB Holdco, Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC, AIIH and LYB Holdco, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC.
Ordinary sharesSEC Table I · non-derivative	IndirectBy LLC	204,253	Reported balance Holding disclosure · report date 2026-03-09 · row 9 Holding and transaction disclosures are not merged. 1 source row Row 9 · Balance 204,253 F2: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F7: Because of their relationships with the other reporting persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC) ("AICH"). Each of the reporting persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of AI Altep Investments LLC and AICH. F11: The securities reported are held directly by AI Altep Investments LLC and may be deemed to be indirectly beneficially owned by Len Blavatnik because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. holds all of the outstanding voting interests in AI Altep Investments LLC.
Ordinary sharesSEC Table I · non-derivative	Direct	765,154	Last balance in matching sequence After 2026-03-09 transaction · row 7 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 3 source rows Row 3 · 2026-03-09 · Sale · Disposed 177 · Balance 765,819 F4: The price reported in Column 4 is a weighted average sales price of the ordinary shares. The ordinary shares were sold in multiple transactions ranging from $66.72 to $67.7193 inclusive. The reporting persons undertake to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F9: The securities reported are held directly by AI Investments Holdings LLC ("AIIH") and may be deemed to be indirectly beneficially owned by Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC and AIIH, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. Row 5 · 2026-03-09 · Sale · Disposed 414 · Balance 765,405 F5: The price reported in Column 4 is a weighted average sales price of the ordinary shares. The ordinary shares were sold in multiple transactions ranging from $67.72 to $68.715 inclusive. The reporting persons undertake to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F9: The securities reported are held directly by AI Investments Holdings LLC ("AIIH") and may be deemed to be indirectly beneficially owned by Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC and AIIH, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. Row 7 · 2026-03-09 · Sale · Disposed 251 · Balance 765,154 F6: The price reported in Column 4 is a weighted average sales price of the ordinary shares. The ordinary shares were sold in multiple transactions ranging from $68.72 to $69.19 inclusive. The reporting persons undertake to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F9: The securities reported are held directly by AI Investments Holdings LLC ("AIIH") and may be deemed to be indirectly beneficially owned by Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC and AIIH, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC.
Ordinary sharesSEC Table I · non-derivative	IndirectBy partnership	16,000,000	Reported balance Holding disclosure · report date 2026-03-09 · row 10 Holding and transaction disclosures are not merged. 1 source row Row 10 · Balance 16,000,000 F2: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F12: The securities reported are held directly by AI European Holdings L.P. ("AIEH") and may be deemed to be indirectly beneficially owned by Access Industries Holdings LLC, Access Industries, LLC, Access Industries Management, LLC, and Len Blavatnik because Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC control, or hold a majority of the outstanding voting interests in, entities that directly or indirectly control AIEH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC and Access Industries Holdings LLC and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC.

Filing footnotes · ownership attribution and instrument terms

F1: These shares were donated by Access Industries Core Holdings LLC (formerly AIPH Holdings LLC) ("AICH") for no consideration as a charitable contribution.

F3: The securities reported are held directly by AICH and may be deemed to be indirectly beneficially owned by Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because Access Industries Holdings LLC controls a majority of the outstanding voting interests in AICH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC and AICH and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC.

F4: The price reported in Column 4 is a weighted average sales price of the ordinary shares. The ordinary shares were sold in multiple transactions ranging from $66.72 to $67.7193 inclusive. The reporting persons undertake to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

F5: The price reported in Column 4 is a weighted average sales price of the ordinary shares. The ordinary shares were sold in multiple transactions ranging from $67.72 to $68.715 inclusive. The reporting persons undertake to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

F6: The price reported in Column 4 is a weighted average sales price of the ordinary shares. The ordinary shares were sold in multiple transactions ranging from $68.72 to $69.19 inclusive. The reporting persons undertake to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

F7: Because of their relationships with the other reporting persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC) ("AICH"). Each of the reporting persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of AI Altep Investments LLC and AICH.

F8: The securities reported are held directly by AICH and may be deemed to be indirectly beneficially owned by Access Industries Management, LLC, Access Industries Holdings LLC and Len Blavatnik because Mr. Blavatnik controls Access Industries Management, LLC, Access Industries Holdings LLC owns a majority of the outstanding voting interests in RSB 2 Limited which is the sole member of AICH, and Access Industries Management, LLC controls AICH and Access Industries Holdings LLC.

F9: The securities reported are held directly by AI Investments Holdings LLC ("AIIH") and may be deemed to be indirectly beneficially owned by Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC and AIIH, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC.

F10: The securities reported are held directly by LYB Holdco LLC (formerly AI International Chemicals LLC) ("LYB Holdco") and may be deemed to be indirectly beneficially owned by AIIH, Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because AIIH holds a majority of the outstanding voting interests in LYB Holdco, Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC, AIIH and LYB Holdco, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC.

F11: The securities reported are held directly by AI Altep Investments LLC and may be deemed to be indirectly beneficially owned by Len Blavatnik because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. holds all of the outstanding voting interests in AI Altep Investments LLC.

F12: The securities reported are held directly by AI European Holdings L.P. ("AIEH") and may be deemed to be indirectly beneficially owned by Access Industries Holdings LLC, Access Industries, LLC, Access Industries Management, LLC, and Len Blavatnik because Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC control, or hold a majority of the outstanding voting interests in, entities that directly or indirectly control AIEH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC and Access Industries Holdings LLC and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC.

OnKure Therapeutics, Inc.

Report date March 31, 2026 · Filed April 08, 2026

Jointly reported with AI Biotechnology LLC, Access Industries Holdings LLC, Blavatnik Len

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	3,998,332	Reported balance Holding disclosure · report date 2026-03-31 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 3,998,332 F2: The securities reported are held directly by AIB and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, and (iii) AIH owns all of the voting units of AIB. Each of AIH, AIM and Mr. Blavatnik, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.
Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Not disclosed	Reported balance Holding disclosure · report date 2026-03-31 · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · Balance Not disclosed F1: Each whole pre-funded warrant entitles AI Biotechnology LLC ("AIB") to purchase one share of Class A Common Stock at an exercise price equal to $0.0001 per share, and may be exercised at any time or times on or after the date of issuance, subject to the Beneficial Ownership Blocker (as defined herein). The pre-funded warrants are not exercisable to the extent that the aggregate number of Class A Common Stock beneficially owned by AIB immediately following such exercise would exceed 9.99% of the Class A Common Stock outstanding, as calculated under Rule 13d-3 of the Securities Exchange Act of 1934, as amended; provided, however, that AIB may increase or decrease the beneficial ownership limitation by giving notice to the Issuer (such notice not to be effective until the sixty-first day after the notice is delivered to the Issuer), but not to exceed any percentage in excess of 19.99% (such limitations, the "Beneficial Ownership Blocker"). F2: The securities reported are held directly by AIB and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, and (iii) AIH owns all of the voting units of AIB. Each of AIH, AIM and Mr. Blavatnik, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.

Filing footnotes · ownership attribution and instrument terms

F1: Each whole pre-funded warrant entitles AI Biotechnology LLC ("AIB") to purchase one share of Class A Common Stock at an exercise price equal to $0.0001 per share, and may be exercised at any time or times on or after the date of issuance, subject to the Beneficial Ownership Blocker (as defined herein). The pre-funded warrants are not exercisable to the extent that the aggregate number of Class A Common Stock beneficially owned by AIB immediately following such exercise would exceed 9.99% of the Class A Common Stock outstanding, as calculated under Rule 13d-3 of the Securities Exchange Act of 1934, as amended; provided, however, that AIB may increase or decrease the beneficial ownership limitation by giving notice to the Issuer (such notice not to be effective until the sixty-first day after the notice is delivered to the Issuer), but not to exceed any percentage in excess of 19.99% (such limitations, the "Beneficial Ownership Blocker").

F2: The securities reported are held directly by AIB and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, and (iii) AIH owns all of the voting units of AIB. Each of AIH, AIM and Mr. Blavatnik, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.

Pandion Therapeutics, Inc.

Report date July 16, 2020 · Filed July 16, 2020

Jointly reported with Access Industries Holdings LLC, AI Pan LLC, Blavatnik Len

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Series B Preferred StockSEC Table II · derivative / convertible security	IndirectSee footnote	Not disclosed	Reported balance Holding disclosure · report date 2020-07-16 · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · Balance Not disclosed F1: The Series B Preferred Stock is convertible into Common Stock on a 5.0994-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares have no expiration date. F2: The securities reported are held directly by AI Pan LLC ("AI Pan"). Each of Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik may be deemed to beneficially own the shares of the Issuer's Common Stock beneficially owned by AI Pan, a subsidiary in a multi-tier corporate structure of which Access Industries Holdings LLC is the parent holding company and is ultimately managed by Access Industries Management, LLC and controlled by Mr. Blavatnik.

Filing footnotes · ownership attribution and instrument terms

F1: The Series B Preferred Stock is convertible into Common Stock on a 5.0994-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares have no expiration date.

F2: The securities reported are held directly by AI Pan LLC ("AI Pan"). Each of Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik may be deemed to beneficially own the shares of the Issuer's Common Stock beneficially owned by AI Pan, a subsidiary in a multi-tier corporate structure of which Access Industries Holdings LLC is the parent holding company and is ultimately managed by Access Industries Management, LLC and controlled by Mr. Blavatnik.

Upstream Bio, Inc.

Report date October 15, 2024 · Filed October 17, 2024

Jointly reported with AI Upstream LLC, AI Biotechnology LLC, Access Industries Holdings LLC, Blavatnik Len

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	5,494,410	Last balance in matching sequence After 2024-10-15 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 3 source rows Row 1 · 2024-10-15 · Purchase · Acquired 1,175,000 · Balance 1,175,000 F2: The securities reported are held directly by AI Upstream LLC ("AI Upstream") and may be deemed to be beneficially owned by AI Biotechnology LLC ("AI Biotechnology"), Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, (iii) AIH owns all of the voting units of AI Biotechnology and (iv) AI Biotechnology owns all of the voting units of AI Upstream. Each of the reporting persons (other than AI Upstream) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form. Row 2 · 2024-10-15 · Conversion · Acquired 3,147,000 · Balance 4,322,000 F1: Each share of the Issuer's Series A preferred stock and Series B preferred stock (collectively, the "Preferred Stock") converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Preferred Stock had no expiration date. F2: The securities reported are held directly by AI Upstream LLC ("AI Upstream") and may be deemed to be beneficially owned by AI Biotechnology LLC ("AI Biotechnology"), Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, (iii) AIH owns all of the voting units of AI Biotechnology and (iv) AI Biotechnology owns all of the voting units of AI Upstream. Each of the reporting persons (other than AI Upstream) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form. Row 3 · 2024-10-15 · Conversion · Acquired 1,172,410 · Balance 5,494,410 F1: Each share of the Issuer's Series A preferred stock and Series B preferred stock (collectively, the "Preferred Stock") converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Preferred Stock had no expiration date. F2: The securities reported are held directly by AI Upstream LLC ("AI Upstream") and may be deemed to be beneficially owned by AI Biotechnology LLC ("AI Biotechnology"), Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, (iii) AIH owns all of the voting units of AI Biotechnology and (iv) AI Biotechnology owns all of the voting units of AI Upstream. Each of the reporting persons (other than AI Upstream) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.
Series A Convertible Preferred StockSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2024-10-15 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2024-10-15 · Conversion · Disposed 3,147,000 · Balance 0 F1: Each share of the Issuer's Series A preferred stock and Series B preferred stock (collectively, the "Preferred Stock") converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Preferred Stock had no expiration date. F2: The securities reported are held directly by AI Upstream LLC ("AI Upstream") and may be deemed to be beneficially owned by AI Biotechnology LLC ("AI Biotechnology"), Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, (iii) AIH owns all of the voting units of AI Biotechnology and (iv) AI Biotechnology owns all of the voting units of AI Upstream. Each of the reporting persons (other than AI Upstream) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.
Series B Convertible Preferred StockSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2024-10-15 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2024-10-15 · Conversion · Disposed 1,172,410 · Balance 0 F1: Each share of the Issuer's Series A preferred stock and Series B preferred stock (collectively, the "Preferred Stock") converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Preferred Stock had no expiration date. F2: The securities reported are held directly by AI Upstream LLC ("AI Upstream") and may be deemed to be beneficially owned by AI Biotechnology LLC ("AI Biotechnology"), Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, (iii) AIH owns all of the voting units of AI Biotechnology and (iv) AI Biotechnology owns all of the voting units of AI Upstream. Each of the reporting persons (other than AI Upstream) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of the Issuer's Series A preferred stock and Series B preferred stock (collectively, the "Preferred Stock") converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Preferred Stock had no expiration date.

F2: The securities reported are held directly by AI Upstream LLC ("AI Upstream") and may be deemed to be beneficially owned by AI Biotechnology LLC ("AI Biotechnology"), Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, (iii) AIH owns all of the voting units of AI Biotechnology and (iv) AI Biotechnology owns all of the voting units of AI Upstream. Each of the reporting persons (other than AI Upstream) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.

Verona Pharma plc

Report date August 15, 2022 · Filed August 17, 2022

Jointly reported with Access Industries Holdings LLC, AI Biotechnology LLC, Blavatnik Len

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	IndirectBy AI Biotechnology LLC	55,911,648	Reported balance After 2022-08-15 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2022-08-15 · Purchase · Acquired 4,800,000 · Balance 55,911,648 F1: Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight ordinary shares of the Issuer. F2: The price reported represents the purchase price of the ADSs divided by eight. F3: The securities reported are held directly by AI Biotechnology LLC ("AIB") and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because Len Blavatnik controls AIM and controls a majority of the outstanding voting interests in AIH, AIM controls AIH, and AIH controls all of the outstanding voting interests in AIB. Each of the reporting persons (other than AIB) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.

Filing footnotes · ownership attribution and instrument terms

F1: Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight ordinary shares of the Issuer.

F2: The price reported represents the purchase price of the ADSs divided by eight.

F3: The securities reported are held directly by AI Biotechnology LLC ("AIB") and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because Len Blavatnik controls AIM and controls a majority of the outstanding voting interests in AIH, AIM controls AIH, and AIH controls all of the outstanding voting interests in AIB. Each of the reporting persons (other than AIB) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.

Warner Music Group Corp.

Report date April 16, 2026 · Filed April 20, 2026

Jointly reported with AI Entertainment Holdings LLC, AIBFF, Inc., ACCESS INDUSTRIES, LLC, Access Industries Core Holdings LLC, Access Industries Holdings LLC, Entertainment Holdings II LLC, Blavatnik Len

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class B Common StockSEC Table II · derivative / convertible security	IndirectBy trust	1,120,000	Reported balance After 2026-04-16 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2026-04-16 · Other · Disposed 280,000 · Balance 1,120,000 F1: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F5: On April 16, 2026, LB 2020 Family Trust (the "Trust") made a distribution for no consideration of an aggregate of 280,000 shares of Class B Common Stock to VLB Holdings LLC. F6: The securities reported are held directly by the Trust and may be deemed to be beneficially owned by Mr. Blavatnik because Mr. Blavatnik is a co-trustee of the Trustee. Each of the reporting persons (other than the Trust) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities.
Class B Common StockSEC Table II · derivative / convertible security	Direct	247,600,227	Reported balance Holding disclosure · report date 2026-04-16 · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · Balance 247,600,227 F1: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F2: The securities reported are held directly by AI Entertainment Holdings LLC ("AIEH") and may be deemed to be beneficially owned by Access Industries Core Holdings LLC (formerly known as AIPH Holdings, LLC) ("AICH"), Access Industries Holdings LLC ("AIH"), Access Industries, LLC ("AI"), Access Industries Management, LLC ("AIM") and Mr. Blavatnik because AIPH is the parent of AIEH, AIH controls a majority of the outstanding voting interests in AIPH, AI controls a majority of the outstanding voting interests in AIH, AIM controls AI and AIH and Mr. Blavatnik is the controlling person of AIM and controls a majority of the outstanding voting interests in AI. Each of the reporting persons (other than AIEH) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities.
Class B Common StockSEC Table II · derivative / convertible security	IndirectBy corporation	517,025	Reported balance Holding disclosure · report date 2026-04-16 · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · Balance 517,025 F1: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F3: The securities reported are held directly by AIBFF, Inc. (formerly known as AI Altep Holdings, Inc.) ("AIBFF") and may be deemed to be beneficially owned by Mr. Blavatnik because Mr. Blavatnik controls AIBFF. Each of the reporting persons (other than AIBFF) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities.
Class B Common StockSEC Table II · derivative / convertible security	IndirectBy corporation	125,000,000	Reported balance Holding disclosure · report date 2026-04-16 · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · Balance 125,000,000 F1: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F4: The securities reported are held directly by Entertainment Holdings II LLC ("EH") and may be deemed to be beneficially owned by AIEH, AICH, AIH, AI, AIM and Mr. Blavatnik because AIEH is the parent of EH, AICH is the parent of AIEH, AIH controls a majority of the outstanding voting interests in AICH, AI controls a majority of the outstanding voting interests in AIH, AIM controls AI and AIH and Mr. Blavatnik is the controlling person of AIM and controls a majority of the outstanding voting interests in AI. Each of the reporting persons (other than EH), and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date.

F2: The securities reported are held directly by AI Entertainment Holdings LLC ("AIEH") and may be deemed to be beneficially owned by Access Industries Core Holdings LLC (formerly known as AIPH Holdings, LLC) ("AICH"), Access Industries Holdings LLC ("AIH"), Access Industries, LLC ("AI"), Access Industries Management, LLC ("AIM") and Mr. Blavatnik because AIPH is the parent of AIEH, AIH controls a majority of the outstanding voting interests in AIPH, AI controls a majority of the outstanding voting interests in AIH, AIM controls AI and AIH and Mr. Blavatnik is the controlling person of AIM and controls a majority of the outstanding voting interests in AI. Each of the reporting persons (other than AIEH) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities.

F3: The securities reported are held directly by AIBFF, Inc. (formerly known as AI Altep Holdings, Inc.) ("AIBFF") and may be deemed to be beneficially owned by Mr. Blavatnik because Mr. Blavatnik controls AIBFF. Each of the reporting persons (other than AIBFF) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities.

F4: The securities reported are held directly by Entertainment Holdings II LLC ("EH") and may be deemed to be beneficially owned by AIEH, AICH, AIH, AI, AIM and Mr. Blavatnik because AIEH is the parent of EH, AICH is the parent of AIEH, AIH controls a majority of the outstanding voting interests in AICH, AI controls a majority of the outstanding voting interests in AIH, AIM controls AI and AIH and Mr. Blavatnik is the controlling person of AIM and controls a majority of the outstanding voting interests in AI. Each of the reporting persons (other than EH), and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities.

F5: On April 16, 2026, LB 2020 Family Trust (the "Trust") made a distribution for no consideration of an aggregate of 280,000 shares of Class B Common Stock to VLB Holdings LLC.

F6: The securities reported are held directly by the Trust and may be deemed to be beneficially owned by Mr. Blavatnik because Mr. Blavatnik is a co-trustee of the Trustee. Each of the reporting persons (other than the Trust) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities.

Yarrow Bioscience, Inc.

Report date November 01, 2023 · Filed November 13, 2023

Jointly reported with AI Biotechnology LLC, Access Industries Holdings LLC, Blavatnik Len

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,116,585	Reported balance Holding disclosure · report date 2023-11-01 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 1,116,585 F1: The securities reported are held directly by AI Biotechnology LLC ("AI Biotechnology") and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, and (iii) AIH owns all of the voting units of AI Biotechnology. Each of the reporting persons (other than AI Biotechnology) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.
Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Not disclosed	Reported balance Holding disclosure · report date 2023-11-01 · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · Balance Not disclosed F2: Each pre-funded warrant is exercisable at any time after the date of issuance and the pre-funded warrants do not expire. The pre-funded warrants are not exercisable to the extent that the aggregate number of shares of Common Stock beneficially owned by AI Biotechnology immediately following such exercise would exceed 9.99%; provided, however, that AI Biotechnology may increase or decrease the beneficial ownership limitation by giving 60 days' notice to the Issuer, but not to exceed any percentage in excess of 19.99%.

Filing footnotes · ownership attribution and instrument terms

F1: The securities reported are held directly by AI Biotechnology LLC ("AI Biotechnology") and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, and (iii) AIH owns all of the voting units of AI Biotechnology. Each of the reporting persons (other than AI Biotechnology) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.

F2: Each pre-funded warrant is exercisable at any time after the date of issuance and the pre-funded warrants do not expire. The pre-funded warrants are not exercisable to the extent that the aggregate number of shares of Common Stock beneficially owned by AI Biotechnology immediately following such exercise would exceed 9.99%; provided, however, that AI Biotechnology may increase or decrease the beneficial ownership limitation by giving 60 days' notice to the Issuer, but not to exceed any percentage in excess of 19.99%.

Zura Bio Ltd

Report date February 26, 2026 · Filed March 02, 2026

Jointly reported with AI Biotechnology LLC, Access Industries Holdings LLC, Blavatnik Len

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Ordinary SharesSEC Table I · non-derivative	Direct	6,552,725	Reported balance After 2026-02-26 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2026-02-26 · Purchase · Acquired 2,000,000 · Balance 6,552,725 F1: Shares of Class A Ordinary Shares acquired pursuant to a registered offering of Class A Ordinary Shares by the Issuer. F2: The securities reported are held directly by AI Biotechnology LLC ("AIB") and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, and (iii) AIH owns all of the voting units of AIB. Each of AIH, AIM and Mr. Blavatnik, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.

Filing footnotes · ownership attribution and instrument terms

F1: Shares of Class A Ordinary Shares acquired pursuant to a registered offering of Class A Ordinary Shares by the Issuer.

F2: The securities reported are held directly by AI Biotechnology LLC ("AIB") and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, and (iii) AIH owns all of the voting units of AIB. Each of AIH, AIM and Mr. Blavatnik, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.

Past disclosures · reporting ended (3)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Day One Biopharmaceuticals, Inc.

Report date April 23, 2026 · Filed April 27, 2026

Jointly reported with AI Day1 LLC, Access Industries Holdings LLC, Blavatnik Len

Section 16 reporting ended · disclosed 2026-04-27. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2026-04-23 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2026-04-23 · Other · Disposed 12,929,322 · Balance 0 F1: On April 9, 2026, AI Day1 tendered all of its shares of Common Stock pursuant to the tender offer by Servier Detroit Inc. ("Purchaser") to purchase all of the issued and outstanding shares of Common Stock for $21.50 per share in cash, upon the terms and subject to the conditions described in the Offer to Purchase and related Letter of Transmittal filed with the SEC on Schedule TO on March 26, 2026. Such shares were accepted by the Purchaser on April 23, 2026. On April 23, 2026, in connection with the consummation of the merger, each pre-funded warrant held by AI Day1 to purchase Common Stock was converted into the right to receive $21.4999 per warrant in cash. F2: The securities reported are held directly by AI Day1 LLC ("AI Day1") and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, and (iii) AIH owns all of the voting units of AI Day1. Each of AIH, AIM and Mr. Blavatnik, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.
Pre-Funded Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2026-04-23 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-04-23 · Disposition to issuer · Disposed 827,586 · Balance 0 F1: On April 9, 2026, AI Day1 tendered all of its shares of Common Stock pursuant to the tender offer by Servier Detroit Inc. ("Purchaser") to purchase all of the issued and outstanding shares of Common Stock for $21.50 per share in cash, upon the terms and subject to the conditions described in the Offer to Purchase and related Letter of Transmittal filed with the SEC on Schedule TO on March 26, 2026. Such shares were accepted by the Purchaser on April 23, 2026. On April 23, 2026, in connection with the consummation of the merger, each pre-funded warrant held by AI Day1 to purchase Common Stock was converted into the right to receive $21.4999 per warrant in cash. F3: Each pre-funded warrant is exercisable at any time after the date of issuance and the pre-funded warrants do not expire. The pre-funded warrants are not exercisable to the extent that the aggregate number of shares of Common Stock beneficially owned by AI Day1 LLC, including together with its direct or indirect affiliates, any person acting or who could be deemed to be acting as a group together with the holder, and any other persons whose beneficial ownership of the Common Stock would or could be aggregated with the holder's for the purposes of Section 13(d) or Section 16 of the Exchange Act of 1934, as amended, immediately following such exercise would exceed 9.99%; provided, however, that AI Day1 LLC may increase or decrease the beneficial ownership limitation by giving 61 days' notice to the Issuer, but not to exceed any percentage in excess of 19.99%. F2: The securities reported are held directly by AI Day1 LLC ("AI Day1") and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, and (iii) AIH owns all of the voting units of AI Day1. Each of AIH, AIM and Mr. Blavatnik, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.

Filing footnotes · ownership attribution and instrument terms

F1: On April 9, 2026, AI Day1 tendered all of its shares of Common Stock pursuant to the tender offer by Servier Detroit Inc. ("Purchaser") to purchase all of the issued and outstanding shares of Common Stock for $21.50 per share in cash, upon the terms and subject to the conditions described in the Offer to Purchase and related Letter of Transmittal filed with the SEC on Schedule TO on March 26, 2026. Such shares were accepted by the Purchaser on April 23, 2026. On April 23, 2026, in connection with the consummation of the merger, each pre-funded warrant held by AI Day1 to purchase Common Stock was converted into the right to receive $21.4999 per warrant in cash.

F2: The securities reported are held directly by AI Day1 LLC ("AI Day1") and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because (i) Mr. Blavatnik controls AIM and AIH, (ii) AIM controls AIH, and (iii) AIH owns all of the voting units of AI Day1. Each of AIH, AIM and Mr. Blavatnik, and each of their affiliated entities and the officers, partners, members and managers thereof, disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.

F3: Each pre-funded warrant is exercisable at any time after the date of issuance and the pre-funded warrants do not expire. The pre-funded warrants are not exercisable to the extent that the aggregate number of shares of Common Stock beneficially owned by AI Day1 LLC, including together with its direct or indirect affiliates, any person acting or who could be deemed to be acting as a group together with the holder, and any other persons whose beneficial ownership of the Common Stock would or could be aggregated with the holder's for the purposes of Section 13(d) or Section 16 of the Exchange Act of 1934, as amended, immediately following such exercise would exceed 9.99%; provided, however, that AI Day1 LLC may increase or decrease the beneficial ownership limitation by giving 61 days' notice to the Issuer, but not to exceed any percentage in excess of 19.99%.

Disc Medicine, Inc.

Report date October 22, 2025 · Filed October 24, 2025

Jointly reported with AI DMI LLC, Access Industries Holdings LLC, Blavatnik Len

Section 16 reporting ended · disclosed 2025-10-24. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	2,814,379	Reported balance After 2025-10-22 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2025-10-22 · Sale · Disposed 744,047 · Balance 2,814,379 F1: On October 22, 2025, AI DMI LLC ("AI DMI") sold 744,047 shares of common stock of Disc Medicine, Inc., par value $0.0001 per share, pursuant to an underwritten secondary offering. F2: The securities reported are held directly by AI DMI and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because Len Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH, AIM controls AIH, and AIH indirectly controls all of the outstanding voting interests in AI DMI LLC. Each of the reporting persons (other than AI DMI) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.

Filing footnotes · ownership attribution and instrument terms

F1: On October 22, 2025, AI DMI LLC ("AI DMI") sold 744,047 shares of common stock of Disc Medicine, Inc., par value $0.0001 per share, pursuant to an underwritten secondary offering.

F2: The securities reported are held directly by AI DMI and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because Len Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH, AIM controls AIH, and AIH indirectly controls all of the outstanding voting interests in AI DMI LLC. Each of the reporting persons (other than AI DMI) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.

Neon Therapeutics, Inc.

Report date March 23, 2020 · Filed March 25, 2020

Jointly reported with Access Industries Holdings LLC, Clal Biotechnology Industries Ltd., ACCESS INDUSTRIES, LLC, Blavatnik Len

Section 16 reporting ended · disclosed 2020-03-25. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,896,176	Reported balance After 2020-03-24 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2020-03-24 · Sale · Disposed 117,400 · Balance 1,896,176 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.20 to $2.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2: The securities reported are held directly by Access Industries Holdings LLC ("AIH") and may be deemed to be beneficially owned by Access Industries, LLC ("Access LLC"), Access Industries Management, LLC ("Management LLC") and Len Blavatnik, because Access LLC holds a majority of the outstanding voting interests in AIH, Management LLC controls Access LLC and AIH, and Len Blavatnik controls Management LLC and Access LLC. Each of the reporting persons (other than AIH) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, if any, and this Form shall not be construed as an admission that any such reporting person (other than AIH) is the beneficial owner of such securities for any purpose.
Common StockSEC Table I · non-derivative	IndirectBy corporation	856,304	Reported balance After 2020-03-24 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2020-03-24 · Sale · Disposed 84,286 · Balance 856,304 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.19 to $2.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F4: The securities reported are held directly by Clal Biotechnology Industries Ltd. ("CBI"). AIH, Access LLC, Management LLC and Len Blavatnik may be deemed to beneficially own the securities held directly by CBI because Clal Industries Ltd. ("CI") is the controlling shareholder of CBI, AIH controls CI, Access LLC holds a majority of the outstanding interests in AIH, Management LLC controls Access LLC, and Len Blavatnik controls Management LLC and Access LLC. Each of the reporting persons (other than CBI) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, if any, and this Form shall not be construed as an admission that any such reporting person (other than CBI) is the beneficial owner of such securities for any purpose.
Common StockSEC Table I · non-derivative	IndirectBy corporation	940,590	Reported balance After 2020-03-23 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2020-03-23 · Sale · Disposed 50,358 · Balance 940,590 F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.16 to $2.19, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F4: The securities reported are held directly by Clal Biotechnology Industries Ltd. ("CBI"). AIH, Access LLC, Management LLC and Len Blavatnik may be deemed to beneficially own the securities held directly by CBI because Clal Industries Ltd. ("CI") is the controlling shareholder of CBI, AIH controls CI, Access LLC holds a majority of the outstanding interests in AIH, Management LLC controls Access LLC, and Len Blavatnik controls Management LLC and Access LLC. Each of the reporting persons (other than CBI) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, if any, and this Form shall not be construed as an admission that any such reporting person (other than CBI) is the beneficial owner of such securities for any purpose.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.20 to $2.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.19 to $2.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.16 to $2.19, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
September 08, 2021 Filed Sep 10, 2021 19:01 UTC	Warner Music Group Corp. WMG · Entity 2076	ConversionClass B Common Stock · Derivative	3,133,907	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-055559 · doc4.xml · derivative · entry 5 AI Entertainment Holdings LLC · CIK 0001813621 · 10% owner Altep 2012 L.P. · CIK 0001813892 · Affiliate of 10% Owner AI Altep Holdings, Inc · CIK 0000877116 · Affiliate of 10% Owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · Affiliate of 10% Owner AIPH Holdings LLC · CIK 0001564326 · Affiliate of 10% Owner Access Industries Holdings LLC · CIK 0001391297 · Affiliate of 10% Owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · Affiliate of 10% Owner Blavatnik Len · CIK 0001326628 · Director · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,388,528 Underlying: Class A Common Stock · 3,133,907 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F3 · price: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F3 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F3 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. F1 · ownership.direct: The securities reported are held directly by AI Entertainment Holdings LLC ("AIEH") and may be deemed to be beneficially owned by AIPH Holdings LLC ("AIPH"), Access Industries Holdings LLC ("AIH"), Access Industries, LLC ("AI"), Access Industries Management, LLC ("AIM") and Mr. Blavatnik, because AIPH is the parent of AIEH, AIH controls a majority of the outstanding voting interests in AIPH, AI controls a majority of the outstanding voting interests in AIH, AIM controls AI and AIH and Mr. Blavatnik is the controlling person of AIM and controls a majority of the outstanding voting interests in AI. Each of the reporting persons (other than AIEH) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this Form. Read SEC document
September 08, 2021 Filed Sep 10, 2021 19:01 UTC	Warner Music Group Corp. WMG · Entity 2076	SaleClass A Common Stock	16,365	$37.75	$617,778.75	Disclosure SEC source: 0001209191-21-055559 · doc4.xml · nonDerivative · entry 4 AI Entertainment Holdings LLC · CIK 0001813621 · 10% owner Altep 2012 L.P. · CIK 0001813892 · Affiliate of 10% Owner AI Altep Holdings, Inc · CIK 0000877116 · Affiliate of 10% Owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · Affiliate of 10% Owner AIPH Holdings LLC · CIK 0001564326 · Affiliate of 10% Owner Access Industries Holdings LLC · CIK 0001391297 · Affiliate of 10% Owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · Affiliate of 10% Owner Blavatnik Len · CIK 0001326628 · Director · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By partnership Disclosed balance after: 0 F2 · ownership.nature: The securities reported are held directly by Altep 2012 L.P. ("Altep 2012") and may be deemed to be beneficially owned by AI Altep Holdings, Inc. and Mr. Blavatnik because AI Altep Holdings, Inc. is the general partner of Altep 2012 and Mr. Blavatnik controls AI Altep Holdings, Inc. Each of the reporting persons (other than Altep 2012) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. Read SEC document
September 08, 2021 Filed Sep 10, 2021 19:01 UTC	Warner Music Group Corp. WMG · Entity 2076	ConversionClass A Common Stock	16,365	$0.00	$0.00	Disclosure SEC source: 0001209191-21-055559 · doc4.xml · nonDerivative · entry 3 AI Entertainment Holdings LLC · CIK 0001813621 · 10% owner Altep 2012 L.P. · CIK 0001813892 · Affiliate of 10% Owner AI Altep Holdings, Inc · CIK 0000877116 · Affiliate of 10% Owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · Affiliate of 10% Owner AIPH Holdings LLC · CIK 0001564326 · Affiliate of 10% Owner Access Industries Holdings LLC · CIK 0001391297 · Affiliate of 10% Owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · Affiliate of 10% Owner Blavatnik Len · CIK 0001326628 · Director · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By partnership Disclosed balance after: 16,365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · ownership.nature: The securities reported are held directly by Altep 2012 L.P. ("Altep 2012") and may be deemed to be beneficially owned by AI Altep Holdings, Inc. and Mr. Blavatnik because AI Altep Holdings, Inc. is the general partner of Altep 2012 and Mr. Blavatnik controls AI Altep Holdings, Inc. Each of the reporting persons (other than Altep 2012) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. Read SEC document
September 08, 2021 Filed Sep 10, 2021 19:01 UTC	Warner Music Group Corp. WMG · Entity 2076	SaleClass A Common Stock	3,133,907	$37.75	$118,304,989.25	Disclosure SEC source: 0001209191-21-055559 · doc4.xml · nonDerivative · entry 2 AI Entertainment Holdings LLC · CIK 0001813621 · 10% owner Altep 2012 L.P. · CIK 0001813892 · Affiliate of 10% Owner AI Altep Holdings, Inc · CIK 0000877116 · Affiliate of 10% Owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · Affiliate of 10% Owner AIPH Holdings LLC · CIK 0001564326 · Affiliate of 10% Owner Access Industries Holdings LLC · CIK 0001391297 · Affiliate of 10% Owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · Affiliate of 10% Owner Blavatnik Len · CIK 0001326628 · Director · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · ownership.direct: The securities reported are held directly by AI Entertainment Holdings LLC ("AIEH") and may be deemed to be beneficially owned by AIPH Holdings LLC ("AIPH"), Access Industries Holdings LLC ("AIH"), Access Industries, LLC ("AI"), Access Industries Management, LLC ("AIM") and Mr. Blavatnik, because AIPH is the parent of AIEH, AIH controls a majority of the outstanding voting interests in AIPH, AI controls a majority of the outstanding voting interests in AIH, AIM controls AI and AIH and Mr. Blavatnik is the controlling person of AIM and controls a majority of the outstanding voting interests in AI. Each of the reporting persons (other than AIEH) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this Form. Read SEC document
September 08, 2021 Filed Sep 10, 2021 19:01 UTC	Warner Music Group Corp. WMG · Entity 2076	ConversionClass A Common Stock	3,133,907	$0.00	$0.00	Disclosure SEC source: 0001209191-21-055559 · doc4.xml · nonDerivative · entry 1 AI Entertainment Holdings LLC · CIK 0001813621 · 10% owner Altep 2012 L.P. · CIK 0001813892 · Affiliate of 10% Owner AI Altep Holdings, Inc · CIK 0000877116 · Affiliate of 10% Owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · Affiliate of 10% Owner AIPH Holdings LLC · CIK 0001564326 · Affiliate of 10% Owner Access Industries Holdings LLC · CIK 0001391297 · Affiliate of 10% Owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · Affiliate of 10% Owner Blavatnik Len · CIK 0001326628 · Director · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,133,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: The securities reported are held directly by AI Entertainment Holdings LLC ("AIEH") and may be deemed to be beneficially owned by AIPH Holdings LLC ("AIPH"), Access Industries Holdings LLC ("AIH"), Access Industries, LLC ("AI"), Access Industries Management, LLC ("AIM") and Mr. Blavatnik, because AIPH is the parent of AIEH, AIH controls a majority of the outstanding voting interests in AIPH, AI controls a majority of the outstanding voting interests in AIH, AIM controls AI and AIH and Mr. Blavatnik is the controlling person of AIM and controls a majority of the outstanding voting interests in AI. Each of the reporting persons (other than AIEH) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this Form. Read SEC document
August 12, 2021 Filed Aug 16, 2021 16:21 UTC	Climb Bio, Inc. ELYM · Entity 5064	ConversionSeries B Redeemable Convertible Preferred Stock · Derivative	641,025	$0.00	$0.00	Disclosure SEC source: 0001209191-21-051627 · doc4.xml · derivative · entry 4 AI ETI LLC · CIK 0001871741 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · Affiliate of 10% Owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · Affiliate of 10% Owner Blavatnik Len · CIK 0001326628 · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 641,025 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock was automatically converted into one share of common stock upon the completion of Eliem Therapeutics, Inc.'s (the "Issuer") initial public offering and had no expiration date. F1 · kind: Each share of Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock was automatically converted into one share of common stock upon the completion of Eliem Therapeutics, Inc.'s (the "Issuer") initial public offering and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock was automatically converted into one share of common stock upon the completion of Eliem Therapeutics, Inc.'s (the "Issuer") initial public offering and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock was automatically converted into one share of common stock upon the completion of Eliem Therapeutics, Inc.'s (the "Issuer") initial public offering and had no expiration date. F2 · ownership.direct: The securities reported are held directly by AI ETI LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI ETI LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form. Read SEC document
August 12, 2021 Filed Aug 16, 2021 16:21 UTC	Climb Bio, Inc. ELYM · Entity 5064	ConversionSeries A Redeemable Convertible Preferred Stock · Derivative	3,568,375	$0.00	$0.00	Disclosure SEC source: 0001209191-21-051627 · doc4.xml · derivative · entry 3 AI ETI LLC · CIK 0001871741 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · Affiliate of 10% Owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · Affiliate of 10% Owner Blavatnik Len · CIK 0001326628 · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,568,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock was automatically converted into one share of common stock upon the completion of Eliem Therapeutics, Inc.'s (the "Issuer") initial public offering and had no expiration date. F1 · kind: Each share of Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock was automatically converted into one share of common stock upon the completion of Eliem Therapeutics, Inc.'s (the "Issuer") initial public offering and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock was automatically converted into one share of common stock upon the completion of Eliem Therapeutics, Inc.'s (the "Issuer") initial public offering and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock was automatically converted into one share of common stock upon the completion of Eliem Therapeutics, Inc.'s (the "Issuer") initial public offering and had no expiration date. F2 · ownership.direct: The securities reported are held directly by AI ETI LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI ETI LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form. Read SEC document
August 12, 2021 Filed Aug 16, 2021 16:21 UTC	Climb Bio, Inc. ELYM · Entity 5064	PurchaseCommon Stock	800,000	$12.50	$10,000,000.00	Disclosure SEC source: 0001209191-21-051627 · doc4.xml · nonDerivative · entry 2 AI ETI LLC · CIK 0001871741 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · Affiliate of 10% Owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · Affiliate of 10% Owner Blavatnik Len · CIK 0001326628 · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,009,400 F3 · shares: Represents securities purchased in the Issuer's initial public offering. F2 · ownership.direct: The securities reported are held directly by AI ETI LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI ETI LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form. Read SEC document
August 12, 2021 Filed Aug 16, 2021 16:21 UTC	Climb Bio, Inc. ELYM · Entity 5064	ConversionCommon Stock	4,209,400	$0.00	$0.00	Disclosure SEC source: 0001209191-21-051627 · doc4.xml · nonDerivative · entry 1 AI ETI LLC · CIK 0001871741 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · Affiliate of 10% Owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · Affiliate of 10% Owner Blavatnik Len · CIK 0001326628 · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,209,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each share of Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock was automatically converted into one share of common stock upon the completion of Eliem Therapeutics, Inc.'s (the "Issuer") initial public offering and had no expiration date. F2 · ownership.direct: The securities reported are held directly by AI ETI LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI ETI LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form. Read SEC document
June 01, 2021 Filed Jun 3, 2021 20:42 UTC	Day One Biopharmaceuticals, Inc. DAWN · Entity 51180	ConversionSeries B Redeemable Convertible Preferred Stock · Derivative	741,396	$0.00	$0.00	Disclosure SEC source: 0001209191-21-037697 · doc4.xml · derivative · entry 4 AI Day 1 LLC · CIK 0001863302 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · Affiliate of 10% Owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · Affiliate of 10% Owner Blavatnik Len · CIK 0001326628 · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 741,396 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of common stock of the Issuer immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F2 · derivative.exercise_date: Each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of common stock of the Issuer immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F2 · derivative.expiration_date: Each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of common stock of the Issuer immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F3 · ownership.direct: The securities reported are held directly by AI Day 1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day 1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form. Read SEC document
June 01, 2021 Filed Jun 3, 2021 20:42 UTC	Day One Biopharmaceuticals, Inc. DAWN · Entity 51180	ConversionSeries A Redeemable Convertible Preferred Stock · Derivative	7,761,380	$0.00	$0.00	Disclosure SEC source: 0001209191-21-037697 · doc4.xml · derivative · entry 3 AI Day 1 LLC · CIK 0001863302 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · Affiliate of 10% Owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · Affiliate of 10% Owner Blavatnik Len · CIK 0001326628 · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,761,380 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Redeemable Convertible Preferred Stock automatically converted into one share of common stock of Day One Biopharmaceuticals, Inc. (the "Issuer") immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Redeemable Convertible Preferred Stock automatically converted into one share of common stock of Day One Biopharmaceuticals, Inc. (the "Issuer") immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Redeemable Convertible Preferred Stock automatically converted into one share of common stock of Day One Biopharmaceuticals, Inc. (the "Issuer") immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F3 · ownership.direct: The securities reported are held directly by AI Day 1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day 1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form. Read SEC document
June 01, 2021 Filed Jun 3, 2021 20:42 UTC	Day One Biopharmaceuticals, Inc. DAWN · Entity 51180	PurchaseCommon Stock	875,000	$16.00	$14,000,000.00	Disclosure SEC source: 0001209191-21-037697 · doc4.xml · nonDerivative · entry 2 AI Day 1 LLC · CIK 0001863302 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · Affiliate of 10% Owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · Affiliate of 10% Owner Blavatnik Len · CIK 0001326628 · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,377,776 F4 · kind: Represents securities purchased in the Issuer's initial public offering. F3 · ownership.direct: The securities reported are held directly by AI Day 1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day 1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form. Read SEC document
June 01, 2021 Filed Jun 3, 2021 20:42 UTC	Day One Biopharmaceuticals, Inc. DAWN · Entity 51180	ConversionCommon Stock	8,502,776	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-037697 · doc4.xml · nonDerivative · entry 1 AI Day 1 LLC · CIK 0001863302 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · Affiliate of 10% Owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · Affiliate of 10% Owner Blavatnik Len · CIK 0001326628 · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,502,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Redeemable Convertible Preferred Stock automatically converted into one share of common stock of Day One Biopharmaceuticals, Inc. (the "Issuer") immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F2 · price: Each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of common stock of the Issuer immediately prior to the completion of the Issuer's initial public offering and had no expiration date. F3 · ownership.direct: The securities reported are held directly by AI Day 1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day 1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form. Read SEC document
May 04, 2021 Filed May 6, 2021 22:01 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	32,789	$106.53	$3,492,982.66	Disclosure SEC source: 0001209191-21-030700 · doc4.xml · nonDerivative · entry 12 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By LLCs Disclosed balance after: 8,972,232 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.880 to $106.040, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F7 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. F10 · ownership.direct: Each of Access Industries Management, LLC, Access Industries Holdings LLC and Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by AI Chemical Holdings LLC because Mr. Blavatnik controls Access Industries Management, LLC, Access Industries Holdings LLC owns a majority of the outstanding voting interests in RSB 2 Limited which is the sole member of AI Chemical Holdings LLC, and Access Industries Management, LLC controls AI Chemical Holdings LLC and Access Industries Holdings LLC. Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by AI Altep Investments LLC because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. holds all of the outstanding voting interests in AI Altep Investments LLC. F11 · ownership.direct: The securities reported are held directly as follows: (i) 8,789,837 ordinary shares owned directly by AI Chemical Holdings LLC, and (ii) 182,395 ordinary shares owned directly by AI Altep Investments LLC. Read SEC document
May 04, 2021 Filed May 6, 2021 22:01 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	266,769	$107.42	$28,657,313.03	Disclosure SEC source: 0001209191-21-030700 · doc4.xml · nonDerivative · entry 11 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By LLCs Disclosed balance after: 9,005,021 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.880 to $106.890, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F7 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. F10 · ownership.direct: Each of Access Industries Management, LLC, Access Industries Holdings LLC and Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by AI Chemical Holdings LLC because Mr. Blavatnik controls Access Industries Management, LLC, Access Industries Holdings LLC owns a majority of the outstanding voting interests in RSB 2 Limited which is the sole member of AI Chemical Holdings LLC, and Access Industries Management, LLC controls AI Chemical Holdings LLC and Access Industries Holdings LLC. Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by AI Altep Investments LLC because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. holds all of the outstanding voting interests in AI Altep Investments LLC. F11 · ownership.direct: The securities reported are held directly as follows: (i) 8,789,837 ordinary shares owned directly by AI Chemical Holdings LLC, and (ii) 182,395 ordinary shares owned directly by AI Altep Investments LLC. Read SEC document
May 04, 2021 Filed May 6, 2021 22:01 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	626,076	$108.48	$67,916,912.30	Disclosure SEC source: 0001209191-21-030700 · doc4.xml · nonDerivative · entry 10 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By LLCs Disclosed balance after: 9,271,790 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.920 to $107.930, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F7 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. F10 · ownership.direct: Each of Access Industries Management, LLC, Access Industries Holdings LLC and Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by AI Chemical Holdings LLC because Mr. Blavatnik controls Access Industries Management, LLC, Access Industries Holdings LLC owns a majority of the outstanding voting interests in RSB 2 Limited which is the sole member of AI Chemical Holdings LLC, and Access Industries Management, LLC controls AI Chemical Holdings LLC and Access Industries Holdings LLC. Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by AI Altep Investments LLC because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. holds all of the outstanding voting interests in AI Altep Investments LLC. F11 · ownership.direct: The securities reported are held directly as follows: (i) 8,789,837 ordinary shares owned directly by AI Chemical Holdings LLC, and (ii) 182,395 ordinary shares owned directly by AI Altep Investments LLC. Read SEC document
May 04, 2021 Filed May 6, 2021 22:01 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	25	$106.53	$2,663.23	Disclosure SEC source: 0001209191-21-030700 · doc4.xml · nonDerivative · entry 9 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 41,198,908 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.880 to $106.040, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F9 · ownership.direct: The securities reported are held directly by AI International Chemicals LLC ("AIIC") and may be deemed to be indirectly beneficially owned by AIIH, Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because AIIH holds a majority of the outstanding voting interests in AIIC, Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC, AIIH and AIIC, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. Read SEC document
May 04, 2021 Filed May 6, 2021 22:01 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	204	$107.42	$21,914.43	Disclosure SEC source: 0001209191-21-030700 · doc4.xml · nonDerivative · entry 8 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 41,198,933 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.880 to $106.890, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F9 · ownership.direct: The securities reported are held directly by AI International Chemicals LLC ("AIIC") and may be deemed to be indirectly beneficially owned by AIIH, Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because AIIH holds a majority of the outstanding voting interests in AIIC, Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC, AIIH and AIIC, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. Read SEC document
May 04, 2021 Filed May 6, 2021 22:01 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	480	$108.48	$52,070.54	Disclosure SEC source: 0001209191-21-030700 · doc4.xml · nonDerivative · entry 7 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 41,199,137 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.920 to $107.930, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F9 · ownership.direct: The securities reported are held directly by AI International Chemicals LLC ("AIIC") and may be deemed to be indirectly beneficially owned by AIIH, Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because AIIH holds a majority of the outstanding voting interests in AIIC, Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC, AIIH and AIIC, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. Read SEC document
May 04, 2021 Filed May 6, 2021 22:01 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	17	$106.53	$1,810.99	Disclosure SEC source: 0001209191-21-030700 · doc4.xml · nonDerivative · entry 6 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By partnerships Disclosed balance after: 73,240 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.880 to $106.040, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F6 · ownership.direct: Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by Altep 2010 L.P. ("Altep 2010") and Altep 2014 L.P. ("Altep 2014") because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. is the general partner of each of Altep 2010 and Altep 2014. F7 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. F8 · ownership.direct: The securities reported are held directly as follows: (i) 3,467 ordinary shares by Altep 2010 and (ii) 69,773 ordinary shares by Altep 2014. Read SEC document
May 04, 2021 Filed May 6, 2021 22:01 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	133	$107.42	$14,287.35	Disclosure SEC source: 0001209191-21-030700 · doc4.xml · nonDerivative · entry 5 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By partnerships Disclosed balance after: 73,257 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.880 to $106.890, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F6 · ownership.direct: Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by Altep 2010 L.P. ("Altep 2010") and Altep 2014 L.P. ("Altep 2014") because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. is the general partner of each of Altep 2010 and Altep 2014. F7 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. F8 · ownership.direct: The securities reported are held directly as follows: (i) 3,467 ordinary shares by Altep 2010 and (ii) 69,773 ordinary shares by Altep 2014. Read SEC document
May 04, 2021 Filed May 6, 2021 22:01 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	313	$108.48	$33,954.33	Disclosure SEC source: 0001209191-21-030700 · doc4.xml · nonDerivative · entry 4 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By partnerships Disclosed balance after: 73,390 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.920 to $107.930, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F6 · ownership.direct: Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by Altep 2010 L.P. ("Altep 2010") and Altep 2014 L.P. ("Altep 2014") because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. is the general partner of each of Altep 2010 and Altep 2014. F7 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. F8 · ownership.direct: The securities reported are held directly as follows: (i) 3,467 ordinary shares by Altep 2010 and (ii) 69,773 ordinary shares by Altep 2014. Read SEC document
May 04, 2021 Filed May 6, 2021 22:01 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	7	$106.53	$745.70	Disclosure SEC source: 0001209191-21-030700 · doc4.xml · nonDerivative · entry 3 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 763,102 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.880 to $106.040, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · ownership.direct: The securities reported are held directly by AI Investments Holdings LLC ("AIIH") and may be deemed to be indirectly beneficially owned by Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC and AIIH, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. Read SEC document
May 04, 2021 Filed May 6, 2021 22:01 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	56	$107.42	$6,015.73	Disclosure SEC source: 0001209191-21-030700 · doc4.xml · nonDerivative · entry 2 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 763,109 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.880 to $106.890, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · ownership.direct: The securities reported are held directly by AI Investments Holdings LLC ("AIIH") and may be deemed to be indirectly beneficially owned by Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC and AIIH, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. Read SEC document
May 04, 2021 Filed May 6, 2021 22:01 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	131	$108.48	$14,210.92	Disclosure SEC source: 0001209191-21-030700 · doc4.xml · nonDerivative · entry 1 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 763,165 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.920 to $107.930, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · ownership.direct: The securities reported are held directly by AI Investments Holdings LLC ("AIIH") and may be deemed to be indirectly beneficially owned by Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC and AIIH, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. Read SEC document
March 25, 2021 Filed Mar 30, 2021 17:44 UTC	DigitalOcean Holdings, Inc. DOCN · Entity 2625	PurchaseCommon Stock	2,127,659	$47.00	$99,999,973.00	Disclosure SEC source: 0001209191-21-023548 · doc4.xml · nonDerivative · entry 1 Access Industries Holdings LLC · CIK 0001391297 · Affiliate of 10% Owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · Affiliate of 10% Owner AI Droplet Holdings LLC · CIK 0001849909 · 10% owner AI Droplet Sharing LLC · CIK 0001849905 · 10% owner Blavatnik Len · CIK 0001326628 · Affiliate of 10% Owner AI Droplet Subsidiary LLC · CIK 0001854071 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By LLCs Disclosed balance after: 25,865,449 F1 · ownership.direct: The securities reported are held directly as follows: (i) 23,582,125 shares held directly by AI Droplet Holdings LLC, (ii) 155,665 shares held directly by AI Droplet Sharing LLC and (iii) 2,127,659 shares held directly by AI Droplet Subsidiary LLC. F2 · ownership.direct: Each of Access Industries Management, LLC ("AIM") and Len Blavatnik may be deemed to beneficially own, and share investment and voting power over, the shares held directly by AI Droplet Holdings LLC because (i) AIM is the sole manager of AI Droplet Holdings LLC and (ii) Mr. Blavatnik controls AIM and a majority of the outstanding voting interests in AI Droplet Holdings LLC. Each of AIM and Mr. Blavatnik and each of their affiliated entities and the officers, partners, members, and managers thereof, other than AI Droplet Holdings LLC, disclaims beneficial ownership of the shares held directly by AI Droplet Holdings LLC. Each of the reporting persons (other than AI Droplet Holdings LLC) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, if any, and this Form shall not be construed as an admission that any such reporting person (other than AI Droplet Holdings LLC) is the beneficial owner of such securities for any purpose. F3 · ownership.direct: Each of AIM, Access Industries Holdings LLC ("AIH") and Mr. Blavatnik may be deemed to beneficially own, and share investment and voting power over, the shares held directly by AI Droplet Sharing LLC because (i) AIM is the sole manager of AI Droplet Sharing LLC, (ii) AIH controls a majority of the outstanding voting interests in AI Droplet Sharing LLC and (iii) Mr. Blavatnik controls AIM and a majority of the outstanding voting interests in AIH. Each of AIM, AIH and Mr. Blavatnik and each of their affiliated entities and the officers, partners, members, and managers thereof, other than AI Droplet Sharing LLC, disclaims beneficial ownership of the shares held directly by AI Droplet Sharing LLC. F4 · ownership.direct: Each of AIM, AI Droplet Holdings LLC and Mr. Blavatnik may be deemed to beneficially own, and share investment and voting power over, the shares held directly by AI Droplet Subsidiary LLC because (i) AIM is the sole manager of AI Droplet Holdings LLC, (ii) AI Droplet Holdings LLC owns all of the equity interests in AI Droplet Subsidiary LLC and (iii) Mr. Blavatnik controls AIM and a majority of the outstanding voting interests in AI Droplet Holdings LLC. Each of AIM, AI Droplet Holdings LLC and Mr. Blavatnik and each of their affiliated entities and the officers, partners, members, and managers thereof, other than AI Droplet Subsidiary LLC, disclaims beneficial ownership of the shares held directly by AI Droplet Subsidiary LLC. Read SEC document
March 05, 2021 Filed Mar 9, 2021 22:14 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	OtherOrdinary shares	12,410	$0.00	$0.00	Disclosure SEC source: 0001209191-21-019115 · doc4.xml · nonDerivative · entry 2 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By LLCs Disclosed balance after: 9,897,866 F1 · kind: Reflects distribution of ordinary shares by Altep 2010 and Altep 2011 pursuant to an internal reorganization. F1 · price: Reflects distribution of ordinary shares by Altep 2010 and Altep 2011 pursuant to an internal reorganization. F4 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F5 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. F6 · ownership.direct: The securities reported are held directly as follows: (i) 9,708,142 ordinary shares owned directly by AI Chemical Holdings LLC, and (ii) 189,724 ordinary shares owned directly by AI Altep Investments LLC. F7 · ownership.direct: Each of Access Industries Management, LLC, Access Industries Holdings LLC and Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by AI Chemical Holdings LLC because Mr. Blavatnik controls Access Industries Management, LLC, Access Industries Holdings LLC owns a majority of the outstanding voting interests in RSB 2 Limited which is the sole member of AI Chemical Holdings LLC, and Access Industries Management, LLC controls AI Chemical Holdings LLC and Access Industries Holdings LLC. Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by AI Altep Investments LLC because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. holds all of the outstanding voting interests in AI Altep Investments LLC. Read SEC document
March 05, 2021 Filed Mar 9, 2021 22:14 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	OtherOrdinary shares	12,410	$0.00	$0.00	Disclosure SEC source: 0001209191-21-019115 · doc4.xml · nonDerivative · entry 1 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By partnerships Disclosed balance after: 73,703 F1 · kind: Reflects distribution of ordinary shares by Altep 2010 and Altep 2011 pursuant to an internal reorganization. F1 · price: Reflects distribution of ordinary shares by Altep 2010 and Altep 2011 pursuant to an internal reorganization. F2 · ownership.direct: The securities reported are held directly as follows: (i) 3,513 ordinary shares by Altep 2010, (ii) 0 ordinary shares by Altep 2011, and (iii) 70,190 ordinary shares by Altep 2014. F3 · ownership.direct: Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by Altep 2010 L.P. ("Altep 2010"), Altep 2011 L.P. ("Altep 2011") and Altep 2014 L.P. ("Altep 2014") because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. is the general partner of each of Altep 2010, Altep 2011 and Altep 2014. F4 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F5 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. Read SEC document
March 01, 2021 Filed Mar 3, 2021 23:07 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	88,758	$107.02	$9,498,792.40	Disclosure SEC source: 0001209191-21-017188 · doc4.xml · nonDerivative · entry 9 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By LLCs Disclosed balance after: 9,885,456 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.000 to $107.290, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F6 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. F10 · ownership.direct: Each of Access Industries Management, LLC, Access Industries Holdings LLC and Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by AI Chemical Holdings LLC because Mr. Blavatnik controls Access Industries Management, LLC, Access Industries Holdings LLC owns a majority of the outstanding voting interests in RSB 2 Limited which is the sole member of AI Chemical Holdings LLC, and Access Industries Management, LLC controls AI Chemical Holdings LLC and Access Industries Holdings LLC. Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by AI Altep Investments LLC because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. holds all of the outstanding voting interests in AI Altep Investments LLC. F11 · ownership.direct: The securities reported are held directly as follows: (i) 9,708,142 ordinary shares owned directly by AI Chemical Holdings LLC, and (ii) 177,314 ordinary shares owned directly by AI Altep Investments LLC. Read SEC document
March 01, 2021 Filed Mar 3, 2021 23:07 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	659,929	$106.58	$70,331,933.18	Disclosure SEC source: 0001209191-21-017188 · doc4.xml · nonDerivative · entry 8 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By LLCs Disclosed balance after: 9,974,214 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.000 to $106.985, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F6 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. F10 · ownership.direct: Each of Access Industries Management, LLC, Access Industries Holdings LLC and Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by AI Chemical Holdings LLC because Mr. Blavatnik controls Access Industries Management, LLC, Access Industries Holdings LLC owns a majority of the outstanding voting interests in RSB 2 Limited which is the sole member of AI Chemical Holdings LLC, and Access Industries Management, LLC controls AI Chemical Holdings LLC and Access Industries Holdings LLC. Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by AI Altep Investments LLC because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. holds all of the outstanding voting interests in AI Altep Investments LLC. F11 · ownership.direct: The securities reported are held directly as follows: (i) 9,708,142 ordinary shares owned directly by AI Chemical Holdings LLC, and (ii) 177,314 ordinary shares owned directly by AI Altep Investments LLC. Read SEC document
March 01, 2021 Filed Mar 3, 2021 23:07 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	23,194	$107.02	$2,482,198.69	Disclosure SEC source: 0001209191-21-017188 · doc4.xml · nonDerivative · entry 7 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 41,199,617 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.000 to $107.290, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F9 · ownership.direct: The securities reported are held directly by AI International Chemicals LLC ("AIIC") and may be deemed to be indirectly beneficially owned by AIIH, Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because AIIH holds a majority of the outstanding voting interests in AIIC, Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC, AIIH and AIIC, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. Read SEC document
March 01, 2021 Filed Mar 3, 2021 23:07 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	172,449	$106.58	$18,378,752.18	Disclosure SEC source: 0001209191-21-017188 · doc4.xml · nonDerivative · entry 6 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 41,222,811 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.000 to $106.985, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F9 · ownership.direct: The securities reported are held directly by AI International Chemicals LLC ("AIIC") and may be deemed to be indirectly beneficially owned by AIIH, Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because AIIH holds a majority of the outstanding voting interests in AIIC, Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC, AIIH and AIIC, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. Read SEC document
March 01, 2021 Filed Mar 3, 2021 23:07 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	OtherOrdinary shares	30,293	$0.00	$0.00	Disclosure SEC source: 0001209191-21-017188 · doc4.xml · nonDerivative · entry 5 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By partnerships Disclosed balance after: 86,113 F8 · kind: Reflects the distribution of ordinary shares to limited partners. F8 · price: Reflects the distribution of ordinary shares to limited partners. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F5 · ownership.direct: Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by Altep 2010 L.P. ("Altep 2010"), Altep 2011 L.P. ("Altep 2011") and Altep 2014 L.P. ("Altep 2014") because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. is the general partner of each of Altep 2010, Altep 2011 and Altep 2014. F6 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. F7 · ownership.direct: The securities reported are held directly as follows: (i) 9,540 ordinary shares by Altep 2010, (ii) 6,383 ordinary shares by Altep 2011, and (iii) 70,190 ordinary shares by Altep 2014. Read SEC document
March 01, 2021 Filed Mar 3, 2021 23:07 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	56	$107.02	$5,993.06	Disclosure SEC source: 0001209191-21-017188 · doc4.xml · nonDerivative · entry 4 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By partnerships Disclosed balance after: 116,406 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.000 to $107.290, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F5 · ownership.direct: Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by Altep 2010 L.P. ("Altep 2010"), Altep 2011 L.P. ("Altep 2011") and Altep 2014 L.P. ("Altep 2014") because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. is the general partner of each of Altep 2010, Altep 2011 and Altep 2014. F6 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. F7 · ownership.direct: The securities reported are held directly as follows: (i) 9,540 ordinary shares by Altep 2010, (ii) 6,383 ordinary shares by Altep 2011, and (iii) 70,190 ordinary shares by Altep 2014. Read SEC document
March 01, 2021 Filed Mar 3, 2021 23:07 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	416	$106.58	$44,335.20	Disclosure SEC source: 0001209191-21-017188 · doc4.xml · nonDerivative · entry 3 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By partnerships Disclosed balance after: 116,462 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.000 to $106.985, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F5 · ownership.direct: Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by Altep 2010 L.P. ("Altep 2010"), Altep 2011 L.P. ("Altep 2011") and Altep 2014 L.P. ("Altep 2014") because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. is the general partner of each of Altep 2010, Altep 2011 and Altep 2014. F6 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. F7 · ownership.direct: The securities reported are held directly as follows: (i) 9,540 ordinary shares by Altep 2010, (ii) 6,383 ordinary shares by Altep 2011, and (iii) 70,190 ordinary shares by Altep 2014. Read SEC document
March 01, 2021 Filed Mar 3, 2021 23:07 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	23	$107.02	$2,461.44	Disclosure SEC source: 0001209191-21-017188 · doc4.xml · nonDerivative · entry 2 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 763,296 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.000 to $107.290, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · ownership.direct: The securities reported are held directly by AI Investments Holdings LLC ("AIIH") and may be deemed to be indirectly beneficially owned by Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC and AIIH, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. Read SEC document
March 01, 2021 Filed Mar 3, 2021 23:07 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	175	$106.58	$18,650.63	Disclosure SEC source: 0001209191-21-017188 · doc4.xml · nonDerivative · entry 1 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 763,319 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.000 to $106.985, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · ownership.direct: The securities reported are held directly by AI Investments Holdings LLC ("AIIH") and may be deemed to be indirectly beneficially owned by Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC and AIIH, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. Read SEC document
February 25, 2021 Filed Mar 2, 2021 00:46 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	4,497	$107.35	$482,740.81	Disclosure SEC source: 0001209191-21-015458 · doc4.xml · nonDerivative · entry 3 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 41,395,260 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.0000 to $107.8050, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F7 · ownership.direct: The securities reported are held directly by AI International Chemicals LLC ("AIIC") and may be deemed to be indirectly beneficially owned by AIIH, Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because AIIH holds a majority of the outstanding voting interests in AIIC, Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC, AIIH and AIIC, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. Read SEC document
February 25, 2021 Filed Mar 2, 2021 00:46 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	2	$107.35	$214.69	Disclosure SEC source: 0001209191-21-015458 · doc4.xml · nonDerivative · entry 2 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By partnerships Disclosed balance after: 116,878 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.0000 to $107.8050, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F4 · ownership.direct: Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by Altep 2010 L.P. ("Altep 2010"), Altep 2011 L.P. ("Altep 2011") and Altep 2014 L.P. ("Altep 2014") because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. is the general partner of each of Altep 2010, Altep 2011 and Altep 2014. F5 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. F6 · ownership.direct: The securities reported are held directly as follows: (i) 15,528 ordinary shares by Altep 2010, (ii) 30,735 ordinary shares by Altep 2011, and (iii) 70,615 ordinary shares by Altep 2014. Read SEC document
February 25, 2021 Filed Mar 2, 2021 00:46 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	1	$107.35	$107.35	Disclosure SEC source: 0001209191-21-015458 · doc4.xml · nonDerivative · entry 1 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 763,494 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.0000 to $107.8050, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · ownership.direct: The securities reported are held directly by AI Investments Holdings LLC ("AIIH") and may be deemed to be indirectly beneficially owned by Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC and AIIH, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:27 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	198,236	$107.60	$21,331,105.49	Disclosure SEC source: 0001209191-21-014899 · doc4.xml · nonDerivative · entry 15 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 41,399,757 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.4300 to $107.8300, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F11 · ownership.direct: The securities reported are held directly by AI International Chemicals LLC ("AIIC") and may be deemed to be indirectly beneficially owned by AIIH, Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because AIIH holds a majority of the outstanding voting interests in AIIC, Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC, AIIH and AIIC, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:27 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	277,394	$107.31	$29,766,401.18	Disclosure SEC source: 0001209191-21-014899 · doc4.xml · nonDerivative · entry 14 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 41,597,993 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.4300 to $107.4275, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F11 · ownership.direct: The securities reported are held directly by AI International Chemicals LLC ("AIIC") and may be deemed to be indirectly beneficially owned by AIIH, Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because AIIH holds a majority of the outstanding voting interests in AIIC, Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC, AIIH and AIIC, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:27 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	31,543	$105.62	$3,331,521.19	Disclosure SEC source: 0001209191-21-014899 · doc4.xml · nonDerivative · entry 13 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 41,875,387 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.3800 to $106.3600, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F11 · ownership.direct: The securities reported are held directly by AI International Chemicals LLC ("AIIC") and may be deemed to be indirectly beneficially owned by AIIH, Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because AIIH holds a majority of the outstanding voting interests in AIIC, Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC, AIIH and AIIC, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:27 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	91,264	$104.48	$9,535,664.28	Disclosure SEC source: 0001209191-21-014899 · doc4.xml · nonDerivative · entry 12 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 41,906,930 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.2300 to $104.7500, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F11 · ownership.direct: The securities reported are held directly by AI International Chemicals LLC ("AIIC") and may be deemed to be indirectly beneficially owned by AIIH, Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because AIIH holds a majority of the outstanding voting interests in AIIC, Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC, AIIH and AIIC, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:27 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	105,888	$103.96	$11,007,767.05	Disclosure SEC source: 0001209191-21-014899 · doc4.xml · nonDerivative · entry 11 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 41,998,194 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.2300 to $104.2200, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F11 · ownership.direct: The securities reported are held directly by AI International Chemicals LLC ("AIIC") and may be deemed to be indirectly beneficially owned by AIIH, Access Industries, LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik because AIIH holds a majority of the outstanding voting interests in AIIC, Access Industries Holdings LLC controls a majority of the outstanding voting interests in AIIH, Access Industries, LLC controls a majority of the outstanding voting interests in Access Industries Holdings LLC, Access Industries Management, LLC controls Access Industries, LLC, Access Industries Holdings LLC, AIIH and AIIC, and Mr. Blavatnik controls Access Industries Management, LLC and a majority of the outstanding voting interests in Access Industries, LLC. Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:27 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	2,823	$107.60	$303,767.79	Disclosure SEC source: 0001209191-21-014899 · doc4.xml · nonDerivative · entry 10 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By partnerships Disclosed balance after: 116,880 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.4300 to $107.8300, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F8 · ownership.direct: Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by Altep 2010 L.P. ("Altep 2010"), Altep 2011 L.P. ("Altep 2011") and Altep 2014 L.P. ("Altep 2014") because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. is the general partner of each of Altep 2010, Altep 2011 and Altep 2014. F9 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. F10 · ownership.direct: The securities reported are held directly as follows: (i) 15,528 ordinary shares by Altep 2010, (ii) 30,735 ordinary shares by Altep 2011, and (iii) 70,617 ordinary shares by Altep 2014. Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:27 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	3,950	$107.31	$423,863.84	Disclosure SEC source: 0001209191-21-014899 · doc4.xml · nonDerivative · entry 9 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By partnerships Disclosed balance after: 119,703 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.4300 to $107.4275, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F8 · ownership.direct: Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by Altep 2010 L.P. ("Altep 2010"), Altep 2011 L.P. ("Altep 2011") and Altep 2014 L.P. ("Altep 2014") because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. is the general partner of each of Altep 2010, Altep 2011 and Altep 2014. F9 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. F10 · ownership.direct: The securities reported are held directly as follows: (i) 15,528 ordinary shares by Altep 2010, (ii) 30,735 ordinary shares by Altep 2011, and (iii) 70,617 ordinary shares by Altep 2014. Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:27 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	450	$105.62	$47,528.28	Disclosure SEC source: 0001209191-21-014899 · doc4.xml · nonDerivative · entry 8 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By partnerships Disclosed balance after: 123,653 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.3800 to $106.3600, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F8 · ownership.direct: Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by Altep 2010 L.P. ("Altep 2010"), Altep 2011 L.P. ("Altep 2011") and Altep 2014 L.P. ("Altep 2014") because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. is the general partner of each of Altep 2010, Altep 2011 and Altep 2014. F9 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. F10 · ownership.direct: The securities reported are held directly as follows: (i) 15,528 ordinary shares by Altep 2010, (ii) 30,735 ordinary shares by Altep 2011, and (iii) 70,617 ordinary shares by Altep 2014. Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:27 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	1,299	$104.48	$135,725.24	Disclosure SEC source: 0001209191-21-014899 · doc4.xml · nonDerivative · entry 7 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By partnerships Disclosed balance after: 124,103 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.2300 to $104.7500, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F8 · ownership.direct: Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by Altep 2010 L.P. ("Altep 2010"), Altep 2011 L.P. ("Altep 2011") and Altep 2014 L.P. ("Altep 2014") because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. is the general partner of each of Altep 2010, Altep 2011 and Altep 2014. F9 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. F10 · ownership.direct: The securities reported are held directly as follows: (i) 15,528 ordinary shares by Altep 2010, (ii) 30,735 ordinary shares by Altep 2011, and (iii) 70,617 ordinary shares by Altep 2014. Read SEC document
February 24, 2021 Filed Feb 26, 2021 22:27 UTC	LyondellBasell Industries N.V. LYB · Entity 3246	SaleOrdinary shares	1,507	$103.96	$156,662.75	Disclosure SEC source: 0001209191-21-014899 · doc4.xml · nonDerivative · entry 6 AI INVESTMENTS HOLDINGS LLC · CIK 0001508237 · 10% owner Access Industries Holdings LLC · CIK 0001391297 · 10% owner ACCESS INDUSTRIES, LLC · CIK 0001508227 · 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC · CIK 0001508226 · 10% owner Blavatnik Len · CIK 0001326628 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By partnerships Disclosed balance after: 125,402 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.2300 to $104.2200, inclusive. The reporting person undertakes to provide to LyondellBasell Industries N.V., any security holder of LyondellBasell Industries N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · ownership.direct: Each of the reporting persons (other than the direct holder) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this Form shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. F8 · ownership.direct: Len Blavatnik may be deemed to indirectly beneficially own the ordinary shares held directly by Altep 2010 L.P. ("Altep 2010"), Altep 2011 L.P. ("Altep 2011") and Altep 2014 L.P. ("Altep 2014") because he controls AI Altep Holdings, Inc. and AI Altep Holdings, Inc. is the general partner of each of Altep 2010, Altep 2011 and Altep 2014. F9 · ownership.direct: Because of their relationships with the other Reporting Persons, each of Access Industries Holdings LLC, Access Industries, LLC and Access Industries Management, LLC may be deemed to beneficially own the ordinary shares held directly by Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC (formerly AI New Holdings LLC) and AI Chemical Holdings LLC (formerly, AI New Holdings 2 LLC). Each of the Reporting Persons, and each of their affiliated entities and the officers, partners, members, and managers thereof, disclaims beneficial ownership of the ordinary shares held directly by each of Altep 2010, Altep 2011, Altep 2014, AI Altep Investments LLC and AI Chemical Holdings LLC. F10 · ownership.direct: The securities reported are held directly as follows: (i) 15,528 ordinary shares by Altep 2010, (ii) 30,735 ordinary shares by Altep 2011, and (iii) 70,617 ordinary shares by Altep 2014. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.